THE MEDIPHARM CO.,Ltd. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was KRW 3,196.84 million compared to KRW 682.26 million a year ago. Net loss was KRW 1,182.86 million compared to KRW 3,040.9 million a year ago.

Basic loss per share from continuing operations was KRW 14 compared to KRW 37 a year ago. Basic loss per share was KRW 14 compared to KRW 37 a year ago.